NHD
NHD Distribution is a US-based e-commerce reseller of medical supplies and rapid diagnostic tests, offering COVID-19, influenza, and strep test kits from brands such as Status, INDICAID, and CorDx directly to consumers and small-volume professional buyers through its website.
- Company typePrivate
- Founded2020
- HeadquartersAustin, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What NHD does
NHD, LLC (DBA NHD Distribution) is a US-based direct-to-consumer e-commerce distributor of medical supplies and rapid diagnostic products, operating through the storefront nhddistribution.com. The company curates and resells rapid test kits from multiple upstream manufacturers, with named partner brands including Status, INDICAID, CorDx, and FebriDx. Product categories span COVID-19 antigen tests, influenza A/B tests, strep A tests, drugs of abuse testing supplies, durable medical equipment (DME), over-the-counter products, and point-of-care diagnostics. Pack sizes are tiered from single-test kits up to 25-test bulk packs, and orders above $250 qualify for free shipping.
The business model is straightforward retail resale: NHD purchases finished diagnostic kits from third-party manufacturers and resells them at unit-based retail pricing through its Shopify-style e-commerce site. There is no subscription, no SaaS component, no proprietary test or device, and no disclosed data or software layer. Customer segmentation appears to be a hybrid of individual consumers purchasing single or small packs and small-volume professional buyers (clinics, employers, schools) purchasing larger bulk packs, inferred from the free-shipping threshold and the 25-test bulk offering. No B2B contract infrastructure, no enterprise sales motion, and no managed-services revenue line are visible.
No headcount, management team, funding history, revenue figures, regulatory clearances, patents, or partnerships with disclosed economics were available in the input data. The value proposition is purely convenience aggregation and brand selection at the consumer point of purchase; the underlying technology is the e-commerce platform itself rather than any diagnostic or clinical capability owned by NHD.
NHD firmographics
Firmographics- Name
- NHD
- Legal name
- NHD, LLC
- Website
- https://nhdmedical.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NHD Distribution is a US-based e-commerce reseller of medical supplies and rapid diagnostic tests, offering COVID-19, influenza, and strep test kits from brands such as Status, INDICAID, and CorDx directly to consumers and small-volume professional buyers through its website.
- Ownership category
- akta.pro rank
Where NHD is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Markets served
NHD business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel
Revenue model
- Medical Supply and Diagnostic Product Sales: Revenue generated through direct e-commerce sales of medical supplies and diagnostic products to consumers and healthcare providers. Products are sold as one-time purchases at various unit quantities with tiered pricing based on pack size.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Unit pricing with quantity-based tiers for diagnostic test kits |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
NHD product offering
Product offeringCore offering
NHD Distribution sells diagnostic rapid test kits (COVID-19 antigen, influenza A/B, and strep A) and related medical supplies through a direct-to-consumer e-commerce storefront. Products are sourced from established brands including Status™, INDICAID™, CorDx, and FebriDx, and are offered in a mix of over-the-counter at-home kits for individual consumers and point-of-care professional-use kits in bulk pack sizes for healthcare facilities.
Product overview
NHD Distribution is a medical supply and equipment e-commerce company offering a portfolio of diagnostic rapid tests and medical supplies. The product lineup centers on respiratory and infectious disease testing products including COVID-19 antigen tests (Status™, INDICAID™, CorDx brands), influenza tests (Status™ Flu A&B), and strep throat tests (Status™ Strep A series). Products are organized into collections including COVID-19, Respiratory, Point-of-Care, Over-the-Counter, DME (Durable Medical Equipment), and Drugs of Abuse categories. The company operates as a B2B/B2C distributor offering both professional-use and at-home testing kits with various pack sizes to serve healthcare providers and individual consumers.
Differentiator
Problem solved
Functional benefit
Products and services
- FebriDx Diagnostic test for detecting respiratory infections, sold at $700.00 per unit, targeted at point-of-care and professional clinical use.
- CorDx Tyfast Flu A/B & COVID-19 At Home At-home combo antigen test for influenza A/B and COVID-19, available in 1-pack and 2-pack options at $39.99, aimed at individual consumers.
- Status™ COVID-19/Flu A&B Test Point-of-care diagnostic test for simultaneous detection of COVID-19 and influenza A&B, priced at $315.75, intended for professional clinical use.
- Status COVID-19 Antigen Rapid Test Kit for Home Use OTC Over-the-counter rapid antigen test for COVID-19 home use, offered in 1-test, 2-test, and 25-test kit options starting at $7.99 for individual consumers and bulk buyers.
- INDICAID COVID-19 Rapid Antigen At-Home Test At-home rapid antigen test for COVID-19, containing 2 tests per kit at $14.95, designed for individual consumer self-testing.
- Status™ Flu A&B (25 Tests) Point-of-care professional-use test for influenza A and B detection, sold as a 25-test pack at $262.50, targeting clinics and pharmacies.
- Status™ Strep A Flip (25 Tests) Rapid strep A test in flip-format design, sold as a 25-test pack at $59.99, aimed at professional point-of-care settings.
- INDICAID™ COVID-19 Antigen Test Professional-use COVID-19 antigen test, sold at $133.50 per unit, intended for clinical and point-of-care settings.
- Status™ Strep A Plus Enhanced rapid strep A test for point-of-care diagnostics, priced at $85.95, targeted at professional clinical use.
- Status™ Strep A Strip Strip-format rapid strep A test for professional use, priced at $57.27, designed for point-of-care clinical settings.
- CorDx COVID-19 Ag Test (2 count) COVID-19 antigen test in 2-count bulk packaging, priced at $975.00, aimed at facilities and higher-volume professional buyers.
Companies that use NHD
Customer profileSegments2 records
Ideal customer profiles2 records
NHD technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NHD partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Status Diagnostics (Status™)coreNHD distributes Status™ branded diagnostic products including COVID-19/Flu A&B Test, Flu A&B (25 Tests), Strep A Flip, Strep A Plus, and Strep A Strip. Status is a well-established brand in rapid diagnostic testing.
- INDICAID (INDICAID™)coreNHD distributes INDICAID™ COVID-19 products including the Rapid Antigen At-Home Test and COVID-19 Antigen Test. INDICAID is a recognized brand in rapid antigen testing.
- CorDxcoreNHD distributes CorDx products including Tyfast Flu A/B & COVID-19 Ag Combo Test and COVID-19 Ag Test (2 count).
- FebriDxminorNHD distributes FebriDx diagnostic product at $700.00 per unit, representing a higher-value diagnostic offering in their portfolio.
Recent moves4 records
Expansion highlights3 records
NHD competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Major medical products distributor serving hospitals, pharmacies, and clinics across the US. Comparable because it sells overlapping rapid diagnostic and OTC product lines through its at-Home Solutions and medical segments.
- Henry Schein: Distributor of healthcare products to office-based dental and medical practitioners, including diagnostic tests and OTC items. Comparable because it serves the same SMB clinical buyer that NHD's bulk SKUs target.
- Medline Industries: Large privately held medical supply manufacturer and distributor with deep coverage of clinical diagnostics, PPE, and DME. Comparable as a broad-line competitor whose scale and contracts dwarf NHD's catalog.
- McKesson: Largest US medical-surgical distributor with comprehensive wholesale of diagnostics, OTC products, and DME to providers. Relevant as the dominant scale player NHD competes against for any institutional or bulk-customer relationships.
Direct peers
- Bound Tree Medical: Specialty distributor of medical supplies and diagnostics to EMS, fire, and clinical customers. Comparable as a focused medical supply distributor with online ordering similar to NHD's DTC model.
- Allegro Medical: Online retailer specializing in medical supplies, DME, and home diagnostic products. Comparable as a DTC distributor in the same diagnostic and home-health categories NHD serves.
- Save Rite Medical: Online retailer of medical supplies and diagnostic products serving both consumer and clinical buyers. Comparable for its DTC distribution model and product overlap in rapid tests and DME.
- Concordance Healthcare Solutions: Mid-size medical-surgical distributor offering a broad catalog including rapid diagnostics and DME to acute and non-acute care customers. Most directly comparable in size and product mix to NHD.
- QuickMedical: Online medical supply retailer carrying diagnostics, DME, and OTC products for both consumers and providers. Closely mirrors NHD's e-commerce-first model and product categories.
- Discount Medical Supplies: DTC e-commerce retailer of medical equipment, diagnostics, and OTC supplies. Comparable because it sells overlapping rapid-test and DME SKUs through its own online storefront.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
NHD social profiles
Digital presenceNHD financial estimates
Financial estimateRevenue estimate
Valuation estimate
NHD leadership team
Management profileNumber of profiles
NHD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NHD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NHD
What does NHD do?
NHD Distribution sells diagnostic rapid test kits (COVID-19 antigen, influenza A/B, and strep A) and related medical supplies through a direct-to-consumer e-commerce storefront. Products are sourced from established brands including Status™, INDICAID™, CorDx, and FebriDx, and are offered in a mix of over-the-counter at-home kits for individual consumers and point-of-care professional-use kits in bulk pack sizes for healthcare facilities.
Is NHD a public or private company?
NHD is a private company. It is classified as unknown and is currently operating.
When was NHD founded?
NHD was founded in 2020. It employs 11 to 50 people.
Where is NHD based?
NHD is headquartered in Austin, United States, in the North America region.
How does NHD make money?
One revenue line is on record: medical Supply and Diagnostic Product Sales.
Who are NHD's main competitors?
Broad incumbents on record are Cardinal Health, Henry Schein, Medline Industries and McKesson. Direct peers are Bound Tree Medical, Allegro Medical, Save Rite Medical, Concordance Healthcare Solutions, QuickMedical and Discount Medical Supplies.
Does NHD have an API?
No public API is recorded for NHD.